The clinical stage biotech developing protein therapeutics for cancer and rare diseases posted revenue of $4.3 million in the period, which also did not ...
News
- Acceleron: 1Q Earnings Snapshot
- National coronavirus updates: Pence will not self-quarantine, plans to be at the White House Monday
Lab-made antibodies may be available by end of summer, biotech CEO says. The CEO of biotechnology company Regeneron said he's optimistic about ...
- Puma Biotechnology Inc (PBYI) Q1 2020 Earnings Call Transcript
During 2019, at the American Society of Clinical Oncology Annual Meeting and the San Antonio Breast Cancer Symposium, we presented data from ...
- In the early days of the pandemic, the US government turned down an offer to manufacture millions ...
Bowen's overture was described briefly in an 89-page whistleblower complaint filed this week by Rick Bright, former director of the Biomedical ...
- Lawyers: Investigators recommend whistleblower is reinstated
Dr. Rick Bright headed the Biomedical Advanced Research and Development Authority, a unit of Department of Health and Human Services that ...